General Motors supports the FTC's proposed study of generic drug competition
MLex Summary: General Motors supports the US Federal Trade Commission's proposed collection of information on the anticompetitive activities of pharmaceutical manufacturers saying that GM encourages the use of generic drugs because...To view the full article, register now.
Already a subscriber? Click here to view full article